Keyphrases
Immune Response
100%
Breast Cancer Patients
100%
Tumor Heterogeneity
100%
Tumor
83%
Breast Cancer
50%
Immune Cells
50%
High Heterogeneity
50%
Mutant-allele Tumor Heterogeneity
50%
Low Expression
33%
Tumor-infiltrating Immune Cells
33%
Selection Pressure
33%
CD-8
16%
Metastasis
16%
Overall Survival
16%
Neoantigen
16%
Infiltration
16%
Cancer Genome Atlas
16%
Regulatory T Cells
16%
Cancer Cells
16%
Survival Analysis
16%
Granzyme
16%
Activity Score
16%
Behavioral Characteristics
16%
Treatment Resistance
16%
Programmed Death-ligand 1 (PD-L1)
16%
CD4 T Cells
16%
Tumor-promoting
16%
Antitumor
16%
Perforin
16%
Phenotypic Characteristics
16%
Cytolytic Activity
16%
Tumor-immune System
16%
Intratumoral Heterogeneity
16%
Cytolytic
16%
Immune Parameters
16%
Estrogen Receptor-positive
16%
Immune Infiltration
16%
Triple-negative Tumor
16%
CIBERSORT
16%
IDO2
16%
Real-life Cohort
16%
Adenosine A2A Receptor (A2AR)
16%
T Cell Exhaustion
16%
Exhaustion Marker
16%
CCR4
16%
Medicine and Dentistry
Neoplasm
100%
Immune Response
100%
Tumour Heterogeneity
100%
Breast Cancer
100%
Immunocompetent Cell
66%
Allele
33%
CD8 Antigen
11%
T-Helper Cell
11%
Cancer Cell
11%
Metastatic Carcinoma
11%
Overall Survival
11%
T Cell
11%
Estrogen Receptor
11%
The Cancer Genome Atlas
11%
Survival Analysis
11%
Regulatory T Cell
11%
Perforin
11%
Immune Cell Infiltration
11%
Cell Composition
11%
Granzyme A
11%
Immunology and Microbiology
Immunocompetent Cell
100%
Immune Response
100%
Allele
50%
CD8
16%
T Cell
16%
T-Helper Cell
16%
Regulatory T Cell
16%
Overall Survival
16%
Granzyme
16%
Cancer Cell
16%
Neoantigen
16%
Perforin
16%
Immune Cell Infiltration
16%
CCR4
16%
Cell Composition
16%